APA (7th ed.) Citation

Pfeifer, N. D., Lo, A., Bourdet, D. L., Colley, K., & Singh, D. (2021). Phase I study in healthy participants to evaluate safety, tolerability, and pharmacokinetics of inhaled nezulcitinib, a potential treatment for COVID‐19. Wiley.

Chicago Style (17th ed.) Citation

Pfeifer, Nathan D., Arthur Lo, David L. Bourdet, Kenneth Colley, and Dave Singh. Phase I Study in Healthy Participants to Evaluate Safety, Tolerability, and Pharmacokinetics of Inhaled Nezulcitinib, a Potential Treatment for COVID‐19. Wiley, 2021.

MLA (8th ed.) Citation

Pfeifer, Nathan D., et al. Phase I Study in Healthy Participants to Evaluate Safety, Tolerability, and Pharmacokinetics of Inhaled Nezulcitinib, a Potential Treatment for COVID‐19. Wiley, 2021.